[Current indications for left atrial appendage occlusion]

Area of Science:

• Cardiology
• Medical Devices
• Clinical Practice Guidelines

Background:

• Atrial fibrillation patients face a dual risk of stroke and bleeding.
• Left atrial appendage (LAA) occlusion is a potential intervention to mitigate bleeding risk.
• Existing guidelines require clarification for optimal LAA occluder use.

Purpose of the Study:

• To define the indications for LAA occlusion devices.
• To present a clear decision-making strategy for LAA occlusion in clinical practice.
• To align with European Heart Rhythm Association (EHRA) consensus.

Main Methods:

• Literature analysis of existing studies on LAA occlusion.
• Integration of the European Heart Rhythm Association (EHRA) Consensus Document.
• Development of a practical clinical decision strategy.

Main Results:

• Clearer indications for LAA occluder implantation have been established.
• A structured approach for patient selection and decision-making is provided.
• The strategy aims to optimize the use of LAA occlusion therapy.

Conclusions:

• LAA occlusion offers a viable option for managing bleeding risk in select atrial fibrillation patients.
• The presented strategy facilitates informed clinical decisions regarding LAA occluder use.
• This work supports evidence-based practice for LAA occlusion therapy.